site stats

Enliven therapeutics stock price

WebEnliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology … WebEnliven Therapeutics, Inc. Common Stock (ELVN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

3 Stocks in the Limelight on New Analyst Coverage

WebMar 20, 2024 · ENLV Complete Enlivex Therapeutics Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebView the latest Enliven Therapeutics Inc. (ELVN) stock price, news, historical charts, analyst ratings and financial information from WSJ. ELVN Enliven Therapeutics Inc. … small business popular https://slightlyaskew.org

Stock Quote & Chart Enliven Therapeutics

WebEnliven Therapeutics, Inc. (ELVN) (Delayed Data from NSDQ) $20.72 USD -0.73 (-3.40%) Updated Apr 10, 2024 04:00 PM ET After-Market: $20.45 -0.27 (-1.30%) 7:58 PM ET Add to portfolio Zacks Rank:... WebApr 10, 2024 · 3 Wall Street analysts have issued 1 year target prices for Enliven Therapeutics' shares. Their ELVN share price forecasts range from $27.00 to $27.00. On … WebApr 13, 2024 · According to 9 analysts, the average rating for ELVN stock is "Buy." The 12-month stock price forecast is $32.64, which is an increase of 69.56% from the latest price. high waisted wide legs

ELVN - Enliven Therapeutics Stock Barchart Opinion - Barchart.com

Category:Stock Quote & Chart Enliven Therapeutics

Tags:Enliven therapeutics stock price

Enliven therapeutics stock price

Amended Current Report Filing (8-k/a)

WebCompany profile page for Enliven Therapeutics Inc/CO including stock price, company news, press releases, executives, board members, and contact information WebOct 14, 2024 · In support of the merger, Enliven also intends to raise approximately $165 million in a concurrent private financing co-led by new investors Fairmount and Venrock Healthcare Capital Partners,...

Enliven therapeutics stock price

Did you know?

WebMar 31, 2024 · Presently, Enliven Therapeutics Inc. shares are logging -12.59% during the 52-week period from high price, and 468.59% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.90 and $25.34. Web19 hours ago · Stock Quote & Chart Enliven Therapeutics Stock Quote & Chart Stock Quote NASDAQ GS: ELVN (Common Stock) $21.83 March 16, 2024 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $21.83 Today's High $22.28 Today's Low $21.26 52 Week High $25.34 52 Week Low $3.90 Stock Chart Data Provided by …

Web19 hours ago · The Investor Relations website contains information about Enliven Therapeutics's business for stockholders, potential investors, and financial analysts. WebMar 13, 2024 · Enliven Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 29337E102 (CUSIP Number) March 3, 2024 (Date of Event Which Requires Filing...

WebELVN - Enliven Therapeutics Stock Barchart Opinion - Barchart.com Enliven Therapeutics Inc (ELVN) Tutorial Alerts Watch Help Go To: Overall Average: 64% Buy Overall Average Signal calculated from all 13 indicators. WebApr 3, 2024 · Stock Quote & Chart Historic Price Lookup Analyst Coverage Corporate Governance Docs and Charters Management Board of Directors Financials & Filings SEC Filings IR Resources Email Alerts Contact Us Careers Values Job Opportunities Contact Privacy Policy Terms of Use 6200 Lookout Road Boulder, CO 80301 General & …

WebFeb 23, 2024 · Following the reverse stock split and closing of the merger, there are approximately 41.1 million shares of the combined company's common stock outstanding, with prior Imara stockholders owning ...

WebCo-founder, Chief Executive Officer, and Member of the Board of Directors. Joe Lyssikatos, PhD. Co-founder, Chief Scientific Officer, and Member of the Board of Directors. Anish Patel, PharmD. Co-founder and Chief Operating Officer. Helen Collins, MD. Chief Medical Officer. Ben Hohl. Chief Financial Officer. high waisted wide leg work pantsWebBarchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The Opinions takes up to 5 years' worth of … high waisted wide leg sailor pantsWebApr 11, 2024 · Price greater than or equal to $5 (as a stock below $5 will not likely create significant interest for most investors). ... Enliven Therapeutics: Based in Boulder, CO, ... high waisted wide waistband pantsWebApr 3, 2024 · March 28, 2024. $23.49. 40,028. 1:1. $23.08. $23.71. $22.91. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account … small business health coverage plansWebGet the latest Enliven Therapeutics Inc (ELVN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … small business relief programsWebApr 11, 2024 · A high-level overview of Enliven Therapeutics, Inc. (ELVN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … high waisted winter leggingsWebApr 6, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Enliven Therapeutics stock is Buy based on the current 3 buy ratings for ELVN. The average twelve-month price prediction for Enliven Therapeutics is $27.00 with a high price target of $27.00 and a low price target of $27.00. small business retirement credit